AHR and cardiac hypertrophy: Moreover, PAHs like phenanthrene, a weak aryl hydrocarbon receptor (AHR)-mediated CYP-1 activator, have been shown to induce cardiac hypertrophy in animals through mechanisms such as decreased miR-133 expression, affecting cardiomyocytes’ size and protein content [52].